FORM DEF 14A

Company

NovaBay Pharmaceuticals, Inc.

Filed

February 10, 2026

Period of Report

March 12, 2026

Accession Number

0001437749-26-003571

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →